Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID‐19 cases: Experience from a tertiary intensive care unit
Therapeutic Apheresis and Dialysis · 2025
DOI: 10.1111/1744-9987.14219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Mesut Ayer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: COVID-19, Plasma Exchange, Cytokine Release Syndrome. Die Arbeit nennt 28 Literaturangaben.
Themen: Intensivpflege
Abstract (Originalsprache)
Aim
Several studies have suggested that cytokine release syndrome (CRS) can be controlled by therapeutic plasma exchange (TPE) treatment. In this study, it was aimed to evaluate the efficacy of TPE treatment in patients who developed life‐threatening respiratory failure syndrome (SARS) due to COVID‐19 infection.
Methods
In this retrospective, case–control study, patients, who developed SARS, were infected with the COVID‐19 virus, and required intensive care unit (ICU) admission were included. Patients included in the study were divided into groups according to whether TPE experience or not and if so, how many sessions were applied. Mortality rates of patients in the ICU and 30‐day mortality ratios were evaluated.
Results
A total of 110 patients, 71.8% of whom were male, with a mean age of 59.7 ± 13.3 years, were included in our study. It was observed that 70% of the patients died within a month and 80% of them died during the ICU follow‐up period. The 30‐day mortality rates of patients who underwent TPE at least once and those who never underwent TPE were 72.2% and 67.9%, respectively ( p : 0.617). CRP, D‐dimer, fibrinogen and platelet levels showed to have a decreasing trend after plasmapheresis and fluctuated thereafter. It was observed that procalcitonin and IL‐6 levels were increased in the group that underwent plasmapheresis but decreased in those who did not receive plasmapheresis.
Conclusion
Patients severely infected with SARS‐CoV‐2 showed fluctuations in inflammatory parameters despite TPE treatment; CRS was not suppressed by TPE; and this treatment did not confer survival benefit in this patient group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey.
- Department of Anesthesiology, Intensive Care Unit, Başakşehir Çam and Sakura City Hospital, Intensive Care Unit, Istanbul, Turkey.
- Department of Internal Medicine, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey.
- Department of Emergency Medicine, Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey.
ORCID-Profile: Yasemin Özgür
Zitieren
APA
Ayer, M., Özgür, Y., Turan, G., Yurttaş, N. Ö., Ulusoy, Y., Ekmen, Ş. A., Hanoğlu, D., Eker, E. S., & Öngören, Ş. (2025). Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID‐19 cases: Experience from a tertiary intensive care unit. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14219
Vancouver
Ayer M, Özgür Y, Turan G, Yurttaş NÖ, Ulusoy Y, Ekmen ŞA, et al. Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID‐19 cases: Experience from a tertiary intensive care unit. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.14219
BibTeX
@article{Ayer2025,
author = {Ayer, Mesut and Özgür, Yasemin and Turan, Güldem and Yurttaş, Nurgül Özgür and Ulusoy, Yusuf and Ekmen, Şevket Ali and Hanoğlu, Didem and Eker, Edibe Sevde and Öngören, Şeniz},
title = {Ineffectiveness of therapeutic plasma exchange as a last resort in severe COVID‐19 cases: Experience from a tertiary intensive care unit},
journal = {Therapeutic Apheresis and Dialysis},
year = {2025},
doi = {10.1111/1744-9987.14219}
}
EUVIMED